Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations

The Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) is an eight-item questionnaire designed to assess and quantify the impact of COPD symptoms on health status. COPD exacerbations impair quality of life and are characterized by worsening respiratory symptoms from the stable state....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2012-06, Vol.185 (11), p.1218-1224
Hauptverfasser: MACKAY, Alex J, DONALDSON, Gavin C, PATEL, Anant R. C, JONES, Paul W, HURST, John R, WEDZICHA, Jadwiga A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1224
container_issue 11
container_start_page 1218
container_title American journal of respiratory and critical care medicine
container_volume 185
creator MACKAY, Alex J
DONALDSON, Gavin C
PATEL, Anant R. C
JONES, Paul W
HURST, John R
WEDZICHA, Jadwiga A
description The Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) is an eight-item questionnaire designed to assess and quantify the impact of COPD symptoms on health status. COPD exacerbations impair quality of life and are characterized by worsening respiratory symptoms from the stable state. We hypothesized that CAT scores at exacerbation relate to exacerbation severity as measured by exacerbation duration, lung function impairment, and systemic inflammation. To evaluate the usefulness of the CAT to assess exacerbation severity. One hundred sixty-one patients enrolled in the London COPD cohort completed the CAT at baseline (stable state), exacerbation, and during recovery between April 2010 and June 2011. Frequent exacerbators had significantly higher baseline CAT scores than infrequent exacerbators (19.5 ± 6.6 vs. 16.8 ± 8.0, P = 0.025). In 152 exacerbations, CAT scores rose from an average baseline value of 19.4 ± 6.8 to 24.1 ± 7.3 (P < 0.001) at exacerbation. Change in CAT score from baseline to exacerbation onset was significantly but weakly related to change in C-reactive protein (rho = 0.26, P = 0.008) but not to change in fibrinogen (rho = 0.09, P = 0.351) from baseline to exacerbation. At exacerbation, rises in CAT score were significantly associated with falls in FEV(1) (rho = -0.20, P = 0.032). Median recovery time as judged by symptom diary cards was significantly related to the time taken for the CAT score to return to baseline (rho = 0.42, P = 0.012). The CAT provides a reliable score of exacerbation severity. Baseline CAT scores are elevated in frequent exacerbators. CAT scores increase at exacerbation and reflect severity as determined by lung function and exacerbation duration.
doi_str_mv 10.1164/rccm.201110-1843oc
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1038590256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1018634445</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-29b0839956067ed66edde9640a2a6c56f0d848952bc9e74a73d86acdc26711a43</originalsourceid><addsrcrecordid>eNqNkU1r3DAQhk1padK0f6CHIiiFXpzo29IxONs2ENhAEujNyPKYONhWqpGX5N9XZrct5NST5vC8L6N5iuIjo6eMaXkWvZ9OOWWM0ZIZKYJ_VRwzJVQpbUVf55lWopTS_jwq3iE-UMq4YfRtccR5HoyQx0W8Q-iXcQZEEnqS7oHU9zHMgyfbFlNcfBp2QK6XcQqzi8_kYkBwCOQcMWcmmBO5BUwkBbLZuXFxCcgN7CAO6XltrLfXF2Tz5DzE1qUhzPi-eNO7EeHD4T0p7r5tbusf5dX2-2V9flV6qWkquW2pEdYqTXUFndbQdWC1pI477ZXuaWeksYq33kIlXSU6o53vPNcVY06Kk-Lrvvcxhl9L3rGZBvQwjm6GsGDDqDDKUq70f6DMaCGlVBn9_AJ9CEuc80cyxVll19tniu8pHwNihL55jMOU75ehZpXXrPKavbxmlbetc-jToXppJ-j-Rv7YysCXA-DQu7GPbvYD_uOUlZWlUvwGHBeiqA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1021794970</pqid></control><display><type>article</type><title>Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>MACKAY, Alex J ; DONALDSON, Gavin C ; PATEL, Anant R. C ; JONES, Paul W ; HURST, John R ; WEDZICHA, Jadwiga A</creator><creatorcontrib>MACKAY, Alex J ; DONALDSON, Gavin C ; PATEL, Anant R. C ; JONES, Paul W ; HURST, John R ; WEDZICHA, Jadwiga A</creatorcontrib><description>The Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) is an eight-item questionnaire designed to assess and quantify the impact of COPD symptoms on health status. COPD exacerbations impair quality of life and are characterized by worsening respiratory symptoms from the stable state. We hypothesized that CAT scores at exacerbation relate to exacerbation severity as measured by exacerbation duration, lung function impairment, and systemic inflammation. To evaluate the usefulness of the CAT to assess exacerbation severity. One hundred sixty-one patients enrolled in the London COPD cohort completed the CAT at baseline (stable state), exacerbation, and during recovery between April 2010 and June 2011. Frequent exacerbators had significantly higher baseline CAT scores than infrequent exacerbators (19.5 ± 6.6 vs. 16.8 ± 8.0, P = 0.025). In 152 exacerbations, CAT scores rose from an average baseline value of 19.4 ± 6.8 to 24.1 ± 7.3 (P &lt; 0.001) at exacerbation. Change in CAT score from baseline to exacerbation onset was significantly but weakly related to change in C-reactive protein (rho = 0.26, P = 0.008) but not to change in fibrinogen (rho = 0.09, P = 0.351) from baseline to exacerbation. At exacerbation, rises in CAT score were significantly associated with falls in FEV(1) (rho = -0.20, P = 0.032). Median recovery time as judged by symptom diary cards was significantly related to the time taken for the CAT score to return to baseline (rho = 0.42, P = 0.012). The CAT provides a reliable score of exacerbation severity. Baseline CAT scores are elevated in frequent exacerbators. CAT scores increase at exacerbation and reflect severity as determined by lung function and exacerbation duration.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.201110-1843oc</identifier><identifier>PMID: 22281834</identifier><language>eng</language><publisher>New York, NY: American Thoracic Society</publisher><subject>Aged ; Aged, 80 and over ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; C-Reactive Protein - metabolism ; Chronic obstructive pulmonary disease ; Chronic obstructive pulmonary disease, asthma ; Cohort Studies ; Diaries ; Disease Progression ; Dyspnea ; Female ; Forced Expiratory Volume ; Hospitals ; Humans ; Inflammation Mediators - analysis ; Intensive care medicine ; Male ; Medical sciences ; Mortality ; Patient Participation ; Patients ; Pneumology ; Prospective Studies ; Pulmonary Disease, Chronic Obstructive - diagnosis ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Quality of life ; Questionnaires ; Recruitment ; Reproducibility of Results ; Respiratory Function Tests ; Self Report ; Sensitivity and Specificity ; Severity of Illness Index ; Surveys and Questionnaires</subject><ispartof>American journal of respiratory and critical care medicine, 2012-06, Vol.185 (11), p.1218-1224</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright American Thoracic Society Jun 1, 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-29b0839956067ed66edde9640a2a6c56f0d848952bc9e74a73d86acdc26711a43</citedby><cites>FETCH-LOGICAL-c460t-29b0839956067ed66edde9640a2a6c56f0d848952bc9e74a73d86acdc26711a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4011,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25947904$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22281834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MACKAY, Alex J</creatorcontrib><creatorcontrib>DONALDSON, Gavin C</creatorcontrib><creatorcontrib>PATEL, Anant R. C</creatorcontrib><creatorcontrib>JONES, Paul W</creatorcontrib><creatorcontrib>HURST, John R</creatorcontrib><creatorcontrib>WEDZICHA, Jadwiga A</creatorcontrib><title>Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>The Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) is an eight-item questionnaire designed to assess and quantify the impact of COPD symptoms on health status. COPD exacerbations impair quality of life and are characterized by worsening respiratory symptoms from the stable state. We hypothesized that CAT scores at exacerbation relate to exacerbation severity as measured by exacerbation duration, lung function impairment, and systemic inflammation. To evaluate the usefulness of the CAT to assess exacerbation severity. One hundred sixty-one patients enrolled in the London COPD cohort completed the CAT at baseline (stable state), exacerbation, and during recovery between April 2010 and June 2011. Frequent exacerbators had significantly higher baseline CAT scores than infrequent exacerbators (19.5 ± 6.6 vs. 16.8 ± 8.0, P = 0.025). In 152 exacerbations, CAT scores rose from an average baseline value of 19.4 ± 6.8 to 24.1 ± 7.3 (P &lt; 0.001) at exacerbation. Change in CAT score from baseline to exacerbation onset was significantly but weakly related to change in C-reactive protein (rho = 0.26, P = 0.008) but not to change in fibrinogen (rho = 0.09, P = 0.351) from baseline to exacerbation. At exacerbation, rises in CAT score were significantly associated with falls in FEV(1) (rho = -0.20, P = 0.032). Median recovery time as judged by symptom diary cards was significantly related to the time taken for the CAT score to return to baseline (rho = 0.42, P = 0.012). The CAT provides a reliable score of exacerbation severity. Baseline CAT scores are elevated in frequent exacerbators. CAT scores increase at exacerbation and reflect severity as determined by lung function and exacerbation duration.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>C-Reactive Protein - metabolism</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Chronic obstructive pulmonary disease, asthma</subject><subject>Cohort Studies</subject><subject>Diaries</subject><subject>Disease Progression</subject><subject>Dyspnea</subject><subject>Female</subject><subject>Forced Expiratory Volume</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Inflammation Mediators - analysis</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Patient Participation</subject><subject>Patients</subject><subject>Pneumology</subject><subject>Prospective Studies</subject><subject>Pulmonary Disease, Chronic Obstructive - diagnosis</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Recruitment</subject><subject>Reproducibility of Results</subject><subject>Respiratory Function Tests</subject><subject>Self Report</subject><subject>Sensitivity and Specificity</subject><subject>Severity of Illness Index</subject><subject>Surveys and Questionnaires</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkU1r3DAQhk1padK0f6CHIiiFXpzo29IxONs2ENhAEujNyPKYONhWqpGX5N9XZrct5NST5vC8L6N5iuIjo6eMaXkWvZ9OOWWM0ZIZKYJ_VRwzJVQpbUVf55lWopTS_jwq3iE-UMq4YfRtccR5HoyQx0W8Q-iXcQZEEnqS7oHU9zHMgyfbFlNcfBp2QK6XcQqzi8_kYkBwCOQcMWcmmBO5BUwkBbLZuXFxCcgN7CAO6XltrLfXF2Tz5DzE1qUhzPi-eNO7EeHD4T0p7r5tbusf5dX2-2V9flV6qWkquW2pEdYqTXUFndbQdWC1pI477ZXuaWeksYq33kIlXSU6o53vPNcVY06Kk-Lrvvcxhl9L3rGZBvQwjm6GsGDDqDDKUq70f6DMaCGlVBn9_AJ9CEuc80cyxVll19tniu8pHwNihL55jMOU75ehZpXXrPKavbxmlbetc-jToXppJ-j-Rv7YysCXA-DQu7GPbvYD_uOUlZWlUvwGHBeiqA</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>MACKAY, Alex J</creator><creator>DONALDSON, Gavin C</creator><creator>PATEL, Anant R. C</creator><creator>JONES, Paul W</creator><creator>HURST, John R</creator><creator>WEDZICHA, Jadwiga A</creator><general>American Thoracic Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope></search><sort><creationdate>20120601</creationdate><title>Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations</title><author>MACKAY, Alex J ; DONALDSON, Gavin C ; PATEL, Anant R. C ; JONES, Paul W ; HURST, John R ; WEDZICHA, Jadwiga A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-29b0839956067ed66edde9640a2a6c56f0d848952bc9e74a73d86acdc26711a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>C-Reactive Protein - metabolism</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Chronic obstructive pulmonary disease, asthma</topic><topic>Cohort Studies</topic><topic>Diaries</topic><topic>Disease Progression</topic><topic>Dyspnea</topic><topic>Female</topic><topic>Forced Expiratory Volume</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Inflammation Mediators - analysis</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Patient Participation</topic><topic>Patients</topic><topic>Pneumology</topic><topic>Prospective Studies</topic><topic>Pulmonary Disease, Chronic Obstructive - diagnosis</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Recruitment</topic><topic>Reproducibility of Results</topic><topic>Respiratory Function Tests</topic><topic>Self Report</topic><topic>Sensitivity and Specificity</topic><topic>Severity of Illness Index</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MACKAY, Alex J</creatorcontrib><creatorcontrib>DONALDSON, Gavin C</creatorcontrib><creatorcontrib>PATEL, Anant R. C</creatorcontrib><creatorcontrib>JONES, Paul W</creatorcontrib><creatorcontrib>HURST, John R</creatorcontrib><creatorcontrib>WEDZICHA, Jadwiga A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MACKAY, Alex J</au><au>DONALDSON, Gavin C</au><au>PATEL, Anant R. C</au><au>JONES, Paul W</au><au>HURST, John R</au><au>WEDZICHA, Jadwiga A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>185</volume><issue>11</issue><spage>1218</spage><epage>1224</epage><pages>1218-1224</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>The Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) is an eight-item questionnaire designed to assess and quantify the impact of COPD symptoms on health status. COPD exacerbations impair quality of life and are characterized by worsening respiratory symptoms from the stable state. We hypothesized that CAT scores at exacerbation relate to exacerbation severity as measured by exacerbation duration, lung function impairment, and systemic inflammation. To evaluate the usefulness of the CAT to assess exacerbation severity. One hundred sixty-one patients enrolled in the London COPD cohort completed the CAT at baseline (stable state), exacerbation, and during recovery between April 2010 and June 2011. Frequent exacerbators had significantly higher baseline CAT scores than infrequent exacerbators (19.5 ± 6.6 vs. 16.8 ± 8.0, P = 0.025). In 152 exacerbations, CAT scores rose from an average baseline value of 19.4 ± 6.8 to 24.1 ± 7.3 (P &lt; 0.001) at exacerbation. Change in CAT score from baseline to exacerbation onset was significantly but weakly related to change in C-reactive protein (rho = 0.26, P = 0.008) but not to change in fibrinogen (rho = 0.09, P = 0.351) from baseline to exacerbation. At exacerbation, rises in CAT score were significantly associated with falls in FEV(1) (rho = -0.20, P = 0.032). Median recovery time as judged by symptom diary cards was significantly related to the time taken for the CAT score to return to baseline (rho = 0.42, P = 0.012). The CAT provides a reliable score of exacerbation severity. Baseline CAT scores are elevated in frequent exacerbators. CAT scores increase at exacerbation and reflect severity as determined by lung function and exacerbation duration.</abstract><cop>New York, NY</cop><pub>American Thoracic Society</pub><pmid>22281834</pmid><doi>10.1164/rccm.201110-1843oc</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2012-06, Vol.185 (11), p.1218-1224
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_miscellaneous_1038590256
source MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Aged
Aged, 80 and over
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
C-Reactive Protein - metabolism
Chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, asthma
Cohort Studies
Diaries
Disease Progression
Dyspnea
Female
Forced Expiratory Volume
Hospitals
Humans
Inflammation Mediators - analysis
Intensive care medicine
Male
Medical sciences
Mortality
Patient Participation
Patients
Pneumology
Prospective Studies
Pulmonary Disease, Chronic Obstructive - diagnosis
Pulmonary Disease, Chronic Obstructive - physiopathology
Quality of life
Questionnaires
Recruitment
Reproducibility of Results
Respiratory Function Tests
Self Report
Sensitivity and Specificity
Severity of Illness Index
Surveys and Questionnaires
title Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T02%3A49%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20the%20Chronic%20Obstructive%20Pulmonary%20Disease%20Assessment%20Test%20to%20Evaluate%20Severity%20of%20COPD%20Exacerbations&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=MACKAY,%20Alex%20J&rft.date=2012-06-01&rft.volume=185&rft.issue=11&rft.spage=1218&rft.epage=1224&rft.pages=1218-1224&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.201110-1843oc&rft_dat=%3Cproquest_cross%3E1018634445%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1021794970&rft_id=info:pmid/22281834&rfr_iscdi=true